chrisvoncsefalvay/vaers-outcomes huggingface dataset:
R axilla lymph node selling and R axilla pain started on Saturday 1/2/2021.  R deltoid itching, and redness on 1/3/2021.  Symptoms are ongoing and I will monitor.  Will follow up with office visit if symptoms do not resolve.
I started just having dizzy spells that lasted a second or so daily upon waking or later that night. Within a couple of weeks, I was having a period of really bad Vertigo and would have to stop and hang on to something. My Doctor order some tests and could not find anything. She stated that it could be a side-effect of taking the vaccine.
Pt developed fine, pin point, red rash on face (non-raised, non-pruritic) 15 minutes after vaccination. Given Benadryl 25 mg PO at 3:33 PM. At 4 PM rash had begun to fade. Pt demanded to leave office at 4 PM, advised to go to ER if any untreated effects. Pt has been seen in office since. No further ill effects occurred after vaccination.
1-27-2012 12 cm x 9 cm erythematous annular macular lesion (R) anterolateral thigh - site of MMR and KINRIX vaccines on 1-24-2012. Began 1-25-2012 (increased in size, worsened) 1-26-2012. No pruritic. Non-tender.
Client came to the POD for her Pfizer vaccine. Prior to receiving the vaccine, she stated that she is afraid of needles and feels very anxious about getting the vaccine. After receiving the vaccine, as she walked away from the vaccinator, accompanied by the vaccinator assistant and her fiancée, she started to pass out. She was caught by her fiancée and did not fall. The EMS was called, she was slowly lowered to the floor, protected by a privacy screen and her legs were raised up. She regained consciousness after a few seconds, and immediately starting talking ? stating that she does not have any medical condition, but she has anxiety attacks which cause her to pass out. Client looked pale, sweaty and shaky. Her vital signs were as follows: BP=111/78; Pulse=83. Client stated that she felt better and would wait for 15 minutes and then leave. The EMS arrived, evaluated her but did not transport her to the hospital.
06/26 c/o stomach hurting-had diarrhea 06/26 for three days, no vomiting, c/o chest pain with no shortness of breath. Saw doctor on 06/28 diag: stomach virus-Rx antibiotic. Became better then 07/09/02 c/o stomach ache no diarrhea nor vomiting.
Reactive arthritis of hands and knees Angioedema of the hands/feet/eyes
a blot clot discovered in lung within 2 weeks of first shot.; This is a spontaneous report from a contactable consumer (patient). A 63-year-old patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Lot number En6202, on 28Feb2021 10:45 at single dose in right arm for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient had no known allergies. The patient had no covid prior vaccination. The patient had not tested covid post vaccination. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient had a blot clot discovered in lung within 2 weeks of first shot on 11Mar2021. The event resulted in Physician Office Visit. Treatment included blood thinner for blood clot. The outcome of the event was unknown. The event is serious with hospitalization and disability.  Follow-up attempts are needed. Further information is expected.
On December 28th, while traveling abroad I came down with a fever and hives all over my body. The fever and sore throats are gone but the hives stayed. I get itchy and my head itches at times throughout the day. If I hit something then I get these bumps on me.
Broke out with a bumpy rash all over chest and face (cheeks, chin area).; Almost looks like clogged pores or acne but was not there prior.; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 19Apr2021 at 11:30 as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and mild autoimmune. The patient had a history of allergy to peanuts, pine nuts, avocado, penicillin and sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), ammonium chloride, diphenhydramine hydrochloride, menthol, sodium citrate (BENADRYL) and lifitegrast (XIIDRA) eyedrops; all from unknown date for unknown indication and unknown if ongoing. The patient previously took cefaclor (CECLOR) and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 25Mar2021 at 11:00 as a single dose for COVID-19 immunisation. On 21Apr2021 at 21:00, the patient experienced broke out with a bumpy rash all over my chest and face (cheeks, chin area) which was almost looks like clogged pores or acne but was not there prior. It was slowly subsiding but still present five days later. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events broke out with a bumpy rash all over chest and face (cheeks, chin area) and almost looks like clogged pores or acne but was not there prior was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 09-OCT-2012 03:13, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not provided. Two lot # were involved and the lot # were reported as: 0294AE, expiry date on 06-SEP-2014; and 0395AE, expiry date on 08-NOV-2014. It was unspecified which lot # the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Tightness in chest, chest pain, feels like being stepped on, squeezed, unable to get an entire breath, dizzy, coughing, shortness of breath, tingling sensations.... intermittent from 6/1/21 til today 6/19/21 (still having symptoms). I had "episodes" of these chest pain attacks, some palpitations. After the Urgent Care I was sent to the ED 6/16/21, where I was diagnosed with "GERD" given meds and sent home. DIDN'T help. The next day, chest pain worse, went to another urgent care on 6/17/21, treated with Symbicort, Singular, Tusslin Pearles... symptoms improved a lot, but still lingering chest pain. TO BE CONTINUED.
Recommended dose is 0.3 mL. Actually 0.5 mL dose was given but it was the same supplier. Client reports "feeling nausea like I did with the first dose". This was at 4:20 PM on 6/11/21. PHN discussed and client knows to stay hydrated, she is drinking clear soda. She will rest and try to eat a little. PHN discussed COVID s/s and advised client to seek care at ER is symptoms worsen or seem different from the s/s with her first dose.
One 3/22/03 client noted raised, bumpy rash on Left elbow, Right arm and right side of neck on 3/22/03.  Called Medical Advisor Dr. and referred for evaluation to occupational med facility.  Client stated that she was running a low grade fever.  She experienced muscle aches and fatigue since 3/18.  A 'robust' take with redness and swelling of the left arm noted on 3/20. Client stated that 15 punctures given on 3/11/03.
Headache Arm soreness at injection site Muscle aches Fatigue Nausea
Pt went to ER on 5/8/99, 5/9/99 and 5/11/99 with a 105F-106F fever. He was taking Tylenol and Motrin (alternating) over 3 hours, in addition to cool baths. I could not break the fever. At the time, I was on vacation and no one would believe me, that this was a reaction. He was weak. They said he had an ear infection but he did not have a cold. Dx'd with Autism.
After receiving flu shot, went home and went to sleep. Approximately seven hours later, awoke with rash around waist that progressed to hives all over body and swollen eyelids. No shortness of breath. Missed two days of work. Saw private MD and put on Atarax and Benadryl.
COVID arm; 2 inches in diameter hard area; a little bit itchy rash; rash that is 4 to 5 inches in diameter red blotchy area; a little bit painful; felt like a pin was constantly being stick in and out; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (COVID arm), INJECTION SITE OEDEMA (2 inches in diameter hard area), INJECTION SITE RASH (a little bit itchy rash), RASH (rash that is 4 to 5 inches in diameter red blotchy area) and INJECTION SITE PAIN (a little bit painful) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included MOMETASONE FUROATE (NASONEX) for an unknown indication.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced PAIN IN EXTREMITY (COVID arm), INJECTION SITE OEDEMA (2 inches in diameter hard area), INJECTION SITE RASH (a little bit itchy rash), RASH (rash that is 4 to 5 inches in diameter red blotchy area), INJECTION SITE PAIN (a little bit painful) and INJECTION SITE IRRITATION (felt like a pin was constantly being stick in and out). At the time of the report, PAIN IN EXTREMITY (COVID arm), INJECTION SITE OEDEMA (2 inches in diameter hard area), INJECTION SITE RASH (a little bit itchy rash), RASH (rash that is 4 to 5 inches in diameter red blotchy area), INJECTION SITE PAIN (a little bit painful) and INJECTION SITE IRRITATION (felt like a pin was constantly being stick in and out) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was unknown
No ADR, timing ERROR, 2nd dose given 58 days after 1st  Narrative: Timing ERROR only
Res had palpitations that started in the evening of 8/3/19.  Physician notified.
Patient received SHINGRIX at a retail pharmacy. Reports confusion, visual hallucinations, fevers, extreme fatigue, poor appetite, pain/redness/calor at the injection site (left deltoid).
Pt reported on 5/21/12, 700 PM after vaccination her shoulder start paining after that pain between two shoulders (that start 2 days later) & redness in the back. No rash, no itching. Primary Dr think it might be because of vaccine. Dr. advice pt. to go to ER. Pt went to ER on 5/21/12.
On the evening of 3/21/19 patient was very cold and had chills. In the early morning of 3/22/19 she woke up and was very sore, all over and did not feel good all through the day. She didn't leave the house or do her normal activities. Saturday, 3/23/19 felt better but still not right.
during night , starting getting real dizzy, feels weak, cant look up or down pt is scared of laying down  cannot move has to lay still hurts to move neck, her blood pressure has gone up and has double her pills to compensate for this
Stiff muscles; Muscle achy; Sore arm; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (Sore arm), MUSCULOSKELETAL STIFFNESS (Stiff muscles) and MYALGIA (Muscle achy) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     The patient's past medical history included Urinary tract infection.   On 21-Jan-2021 at 7:30 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 22-Jan-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiff muscles) and MYALGIA (Muscle achy). The patient was treated with PARACETAMOL (TYLENOL) on 21-Jan-2021 for Pain in arm, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm), MUSCULOSKELETAL STIFFNESS (Stiff muscles) and MYALGIA (Muscle achy) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Additional information received included no new significant information.
1st symptom 3/19/21 at 5:30 am - Weakness in fingers on right hand. Called nurse line, they recommended calling EMT. EMT said no stroke but could go to urgent care for further evaluation. Urgent care recomended ER. ER recommended appointment with Neurology 2nd symptom 3/21/21 slight droop on right side of mouth. Went to ER in Hospital. MRI revealed clot. Additional ultra sound of heart and carotid arteries clear. Final diagnosis: Subacute CVA-Lt Centrum Semiovale w/ right facial droop and right hand deficits. Recomendations: Nuerology evaluation, Outpatient PT/OT  for right hamd deficits. Hospitilization: 1 day Hospital Name: Unnamed City: Unnamed     State: Unnamed
Pt received Moderna on 01-05-2021, then Pfizer on 01-09-2021, and then Moderna on 02-03-2021.
Fever, chills, headache, stomach upset, soreness on right arm. This lasted for entire next day and night following the injection.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 60-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 12Feb2021 as dose 1, single (Lot number: RN6201), in left arm, on 05Mar2021 as dose 2, single (Lot number: EN6198), in left arm, on 28Sep2021 as dose 3 (booster), single (Lot number: FF8839), in left arm and on 06Apr2022 as dose 4 (booster), single (Lot number: FK9896) at the age of 60 years, in left arm for covid-19 immunization. The patient's relevant medical history included: "Over weight" (unspecified if ongoing); "diabetic" (unspecified if ongoing); "under active thyroid" (unspecified if ongoing), notes: under active thyroid; "cholesterol" (unspecified if ongoing). The patient's concomitant medications were not reported. No known allergies were reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results, notes: COVID 19 Treatment; (06Jun2022) Negative, notes: After completing the 5 day series of Paxlovid on 06Jun she went back to medical provider and tested NEGATIVE; (14Jun2022) Positive, notes: tested POSITIvE using a home test on 14Jun2022. Therapeutic measures were taken as a result of vaccination failure, covid-19.
Immediate pain and tenderness at injection site. Numbness and tingling in right foot, moving up to right calf within 5 minutes. Numbness and tingling in left foot and leg as well within 10 minutes. Started to move to hands and arms and went to the ER. Tingling and numbness in face at 20 minutes. Treated with IV steroids and benedryl, no effect. Did bloodwork and showed hypocalcemia. They gave me an oral calcium supplement, tingling and numbness did not subside until next day. Intermittent tingling and numbness in legs continuing to present, 3 weeks post injection. Bloodwork by PCP on 3/30/21 showed normal calcium and protein levels but decreased GFR and low vitamin D despite regular supplementation of 6000 IU/day.
Local allergic reaction with redness pain itching swelling and burning for over 24 hours at site of injection as time progressed reaction has grown larger to about 2 inches diameter
Tested positive COVID; Tested positive COVID; This is a spontaneous report received from a contactable consumer (mother) reported for a 16-year-old (reporter's daughter). A 16-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection), via an unspecified route of administration, administered in left upper arm like shoulder on 03Apr2021 11:30 (Batch/Lot Number: EW0150) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The reporter stated that 4 of the family members after getting the first dose of the COVID 19 vaccine tested positive for COVID and then tested negative 7 weeks after the vaccine and wondering if they should still get the second dose of the vaccine. Reporter clarified that herself and family members tested positive for COVID 1 week after getting the first dose of the COVID 19 vaccine and then tested negative 2 weeks after that. Reporter stated herself and daughter was scheduled for the second 6 weeks and 4 days from the first dose. Reporter stated her daughter was tested positive for COVID on 11Apr2021. Reporter stated no her daughter might have taken Advil one day but she does not think so. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021498996 same drug/similar event, different patients;US-PFIZER INC-2021502035 same drug/similar event, different patients;US-PFIZER INC-2021502099 same drug/similar event, different patients
Information was received from a literature article, titled as stated above, concerning a 15-month-old adopted male with a history of eczema, asthma, and a prior adverse reaction to Varivax was referred for further allergic evaluation. Upon initial allergic evaluation, the infant was able to tolerate eggs, milk, wheat, fish, and pork. No medication allergy was documented. His medications included fluticasone 44 mcg 2 puffs daily in the morning for asthma maintenance, and multivitamins. Skin prick testing was positive for Varivax (Oka/Merck) and histamine and negative for egg and MMR II, gelatin, and normal saline solution. The patient's mother described a previous allergic reaction to Varivax (Oka/Merck) as a rash, suggestive of generalized urticaria, for which the patient was prescribed oral prednisone for two days. Intradermal testing revealed a positive reaction to the MMR II as well as histamine, but not to saline. Subsequently the patient received diphenhydramine topical cream to control the itching. When the patient was 18 months old he was admitted to the pediatric intensive care unit for an MMR II graded challenge. The dosing protocol included an initial dose of MMR II of 0.5 ml with a 1:100 dilution, followed at 5 minutes with 0.05 ml with a 1:10 dilution. At 30 minutes 0.5 ml of MMR II was administered at full strength, followed by 0.10 ml full strength at 45 minutes, 0.15 ml full strength at 60 minutes and a final dose of 0.20 ml full strength at 75 minutes. The patient tolerated the procedure without any adverse reaction. It was also noted that the patient had tolerated subsequent vaccinations (unspecified) well. Research suggests that immediate and some non-immediate type reactions to Varivax are caused by anti-gelatin IgG or IgE immune reactions. Most individuals with IgE antibodies to gelatin and type I hypersensitivity to gelatin containing vaccines have not reported allergic reactions to gelatin prior to vaccination. Sensitization to gelatin during infancy may be attributed to prior ingestion of precooked infant food for administration of gelatin containing vaccines. The patient's history suggested the presence of serum IgE antibodies to gelatin. Hypersensitivity after vaccination warrants consideration of gelatin allergy as a potential cause. In the opinion of the reporters hypersensitivity to gelatin, a stabilizing vaccine constituent is associated with anaphylaxis to MMR and varicella vaccines. Adverse reactions to these vaccines are commonly related to gelatin allergy. Individuals with prior hypersensitivity to gelatin-containing vaccines are more likely to experience future adverse reaction to vaccines, and therefore may benefit from a safe and rapid approach, such as a graded-dose protocol. This is one of two reports received from the same source. A copy of this published article is attached as further documentation of the patient's experienced.
Nausea, diaphoresis, cool, pale,  light headed  started 5 minutes after vaccination.   Felt better after 10 minutes.  Did not throw up or pass out.  Vitals 106/70,  pulse 81, RR: 12, o2 sat 99 %
Severe vomiting within 1 to 1/2 hrs. of getting vaccine (Hepatitis A # 1).
pt recvd vax MAY92 & 4 hrs post vax had severe h/a to the point of migraine, was dizzy, had flashing lights, was in tears; treated w/bedrest & advil w/o relief;
Pt recv vax on 11/17/98; on 11/19/98 pt exp hives, swelling, pain & redness at vax site
eye irritation; runny nose; sneezing; allergy in the eyes and nose / some allergies; pain in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of EYE IRRITATION (eye irritation), RHINORRHOEA (runny nose), SNEEZING (sneezing), HYPERSENSITIVITY (allergy in the eyes and nose / some allergies) and VACCINATION SITE PAIN (pain in the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product sitax for an unknown indication.    No Medical History information was reported.   On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started sitax (unknown route) at an unspecified dose. On an unknown date, the patient experienced EYE IRRITATION (eye irritation), RHINORRHOEA (runny nose), SNEEZING (sneezing), HYPERSENSITIVITY (allergy in the eyes and nose / some allergies) and VACCINATION SITE PAIN (pain in the injection site). At the time of the report, EYE IRRITATION (eye irritation), RHINORRHOEA (runny nose), SNEEZING (sneezing), HYPERSENSITIVITY (allergy in the eyes and nose / some allergies) and VACCINATION SITE PAIN (pain in the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication provided was Sitax V 1tab every 3 days. Concomitant medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Patient email address is updated. Patient treatment medication is also updated
About  march 26 i began having shortness of breathe and fatigue. As symptoms increased over the weekend I scheduled a covid test  on the 30th as these symptoms were exhibited by my daughter's family who tested positive for covid. I also called my pulmonary dr on Tues 3/31 and he told me to go to the ER based on erratic data from my CPAP machine. Once at the ER  it was determined that I was having a difficult Afib issue(first time ever for Afib). I was given a successful TEE and cardioversion the next day and was discharged. So my question is was this first time Afib event as a result of an adverse reaction to the second Pfizer vaccine shot??
Fever, chills, fatigue, weakness, soreness all over body, headache,  sweating. These lasted for a day and a half. Treated with fluids throughout the day.